
News|Articles|September 19, 2024
Growth Factor Supplementation: A New Paradigm in Ocular Surface Disease Management
Advertisement
Sponsored Supplement:
Growth factors play a crucial role in maintaining ocular surface homeostasis and health and promoting healing in various ocular disorders. As our understanding of these molecules evolves, so does their potential for therapeutic application. To explore the current state of knowledge and clinical practice regarding growth factors in ocular surface disease, Vital Tears recently convened a roundtable discussion with five internationally renowned clinicians specializing in dry eye and ocular surface disorders: Clara Chan, Minas Coroneo, Pedram Hamrah, Victor L. Perez, and Stephen Pflugfelder
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
Recognizing biomarkers of Alzheimer Disease using OCTA
3
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
4
Midyear cataract check-in: What 2026 has brought to the OR and beyond
5




















